Data in CLL patients showed a 4.15-fold increase in Pax-5 transcripts with short 3′UTR lengths (<200 nts) compared to control primary cells (p < 0.001, Figure 6C). Here, PAX5 is linked to B-cell chronic lymphocytic leukemia.